• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

I型胶原蛋白和二价阳离子变化会破坏胰腺癌细胞间的细胞黏附,增加迁移,并降低甲状旁腺激素相关蛋白(PTHrP)、白细胞介素-6(IL-6)和白细胞介素-8(IL-8)的表达。

Type I collagen and divalent cation shifts disrupt cell-cell adhesion, increase migration, and decrease PTHrP, IL-6, and IL-8 expression in pancreatic cancer cells.

作者信息

Grzesiak John J, Smith Kathy C, Chalberg Cheryl, Burton Douglas W, Deftos Leonard J, Bouvet Michael

机构信息

Department of Surgery, University of California, San Diego and Veterans Affairs, San Diego Healthcare System, San Diego, CA 92161, USA.

出版信息

Int J Gastrointest Cancer. 2005;36(3):131-46. doi: 10.1385/IJGC:36:3:131.

DOI:10.1385/IJGC:36:3:131
PMID:16720909
Abstract

BACKGROUND

We have shown in FG pancreatic cancer cells that alpha2beta1 integrin-mediated type I collagen adhesion decreases parathyroid hormone-related protein (PTHrP), interleukin-6 (IL-6), and interleukin-8 (IL-8) expression, decreases the localization of E-cadherin and beta-catenin in cell-cell contacts, increases cell migration, and increases glycogen synthase kinase 3 (GSK3) and protein kinase B (PKB/Akt) phosphorylation states relative to alpha5beta1 integrin-mediated fibronectin (Fn) adhesion.

AIM OF THE STUDY

To extend our observations in FG cells to other pancreatic cancer cell lines, and to determine whether E-cadherin-mediated cell-cell adhesion and its downstream effectors were functionally involved in the ECM-mediated regulation of PTHrP, IL-6, and IL-8.

METHODS

We used standard biochemical techniques to determine ECM-specific differences in E-cadherin and beta-catenin localization, GSK3 and PKB/Akt phosphorylation, haptokinetic cell migration, and cytokine expression in pancreatic cancer cells. We also conducted functional studies using pharmacological inhibitors for GSK3 and PKB/Akt, as well as elevated Mg2+/Ca2+ ratios similar to pancreatic juice, and examined their effects on cytokine expression.

RESULTS

Differences in E-cadherin and beta-catenin localization along with GSK3 and PKB/Akt phosphorylation occur in multiple pancreatic cancer cell lines, resulting in differences in ECM-mediated haptokinesis and cytokine expression that are generally consistent with previous observations in FG cells. Our functional studies also suggest that E-cadherin-mediated cell-cell adhesion and downstream effectors are involved in PTHrP, IL-6, and IL-8 expression.

CONCLUSIONS

These data indicate that alpha2beta1 integrin-mediated type I collagen adhesion disrupts cell-cell adhesion architecture, resulting in increased migration and decreased PTHrP, IL-6, and IL-8 expression in pancreatic cancer cells.

摘要

背景

我们已经在FG胰腺癌细胞中证实,α2β1整合素介导的I型胶原黏附可降低甲状旁腺激素相关蛋白(PTHrP)、白细胞介素-6(IL-6)和白细胞介素-8(IL-8)的表达,减少E-钙黏蛋白和β-连环蛋白在细胞间接触部位的定位,增加细胞迁移,并相对于α5β1整合素介导的纤连蛋白(Fn)黏附增加糖原合酶激酶3(GSK3)和蛋白激酶B(PKB/Akt)的磷酸化状态。

研究目的

将我们在FG细胞中的观察结果扩展到其他胰腺癌细胞系,并确定E-钙黏蛋白介导的细胞间黏附及其下游效应分子是否在细胞外基质(ECM)介导的PTHrP、IL-6和IL-8调节中发挥功能作用。

方法

我们使用标准生化技术来确定胰腺癌细胞中E-钙黏蛋白和β-连环蛋白定位、GSK3和PKB/Akt磷酸化、触觉运动细胞迁移以及细胞因子表达方面的ECM特异性差异。我们还使用GSK3和PKB/Akt的药理学抑制剂以及类似于胰液的升高的Mg2+/Ca2+比值进行功能研究,并检查它们对细胞因子表达的影响。

结果

多种胰腺癌细胞系中存在E-钙黏蛋白和β-连环蛋白定位以及GSK3和PKB/Akt磷酸化的差异,导致ECM介导的触觉运动和细胞因子表达存在差异,这与之前在FG细胞中的观察结果总体一致。我们的功能研究还表明,E-钙黏蛋白介导的细胞间黏附及其下游效应分子参与了PTHrP、IL-6和IL-8的表达。

结论

这些数据表明,α2β1整合素介导的I型胶原黏附破坏了细胞间黏附结构,导致胰腺癌细胞迁移增加以及PTHrP、IL-6和IL-8表达降低。

相似文献

1
Type I collagen and divalent cation shifts disrupt cell-cell adhesion, increase migration, and decrease PTHrP, IL-6, and IL-8 expression in pancreatic cancer cells.I型胶原蛋白和二价阳离子变化会破坏胰腺癌细胞间的细胞黏附,增加迁移,并降低甲状旁腺激素相关蛋白(PTHrP)、白细胞介素-6(IL-6)和白细胞介素-8(IL-8)的表达。
Int J Gastrointest Cancer. 2005;36(3):131-46. doi: 10.1385/IJGC:36:3:131.
2
GSK3 and PKB/Akt are associated with integrin-mediated regulation of PTHrP, IL-6 and IL-8 expression in FG pancreatic cancer cells.糖原合成酶激酶3(GSK3)和蛋白激酶B(PKB)/Akt与整合素介导的FG胰腺癌细胞中甲状旁腺激素相关蛋白(PTHrP)、白细胞介素-6(IL-6)和白细胞介素-8(IL-8)表达的调控有关。
Int J Cancer. 2005 Apr 20;114(4):522-30. doi: 10.1002/ijc.20748.
3
Activation of the alpha2beta1 integrin-mediated malignant phenotype on type I collagen in pancreatic cancer cells by shifts in the concentrations of extracellular Mg2+ and Ca2+.细胞外镁离子(Mg2+)和钙离子(Ca2+)浓度的变化激活胰腺癌细胞中α2β1整合素介导的I型胶原恶性表型。
Int J Cancer. 2008 May 15;122(10):2199-209. doi: 10.1002/ijc.23368.
4
Collagen type I induces disruption of E-cadherin-mediated cell-cell contacts and promotes proliferation of pancreatic carcinoma cells.I型胶原蛋白会导致E-钙黏蛋白介导的细胞间连接遭到破坏,并促进胰腺癌细胞的增殖。
Cancer Res. 2006 May 1;66(9):4662-71. doi: 10.1158/0008-5472.CAN-05-2804.
5
Integrin-mediated laminin-1 adhesion upregulates CXCR4 and IL-8 expression in pancreatic cancer cells.整合素介导的层粘连蛋白-1黏附上调胰腺癌细胞中CXCR4和IL-8的表达。
Surgery. 2007 Jun;141(6):804-14. doi: 10.1016/j.surg.2006.12.016. Epub 2007 May 4.
6
Parathyroid hormone-related protein regulates cell survival pathways via integrin alpha6beta4-mediated activation of phosphatidylinositol 3-kinase/Akt signaling.甲状旁腺激素相关蛋白通过整合素α6β4介导的磷脂酰肌醇3激酶/蛋白激酶B信号激活来调节细胞存活途径。
Mol Cancer Res. 2009 Jul;7(7):1119-31. doi: 10.1158/1541-7786.MCR-08-0568. Epub 2009 Jul 7.
7
Divalent cations modulate alpha2beta1 integrin-mediated malignancy in a novel 3-dimensional in vitro model of pancreatic cancer.二价阳离子调节新型胰腺癌三维体外模型中α2β1 整合素介导的恶性肿瘤形成。
Pancreas. 2010 Aug;39(6):904-12. doi: 10.1097/MPA.0b013e3181ce60a3.
8
Pancreatic cancer cell glycosylation regulates cell adhesion and invasion through the modulation of α2β1 integrin and E-cadherin function.胰腺癌细胞糖基化通过调节α2β1 整合素和 E-钙黏蛋白功能调控细胞黏附和侵袭。
PLoS One. 2014 May 30;9(5):e98595. doi: 10.1371/journal.pone.0098595. eCollection 2014.
9
The extracellular matrix differentially regulates the expression of PTHrP and the PTH/PTHrP receptor in FG pancreatic cancer cells.细胞外基质差异性调节FG胰腺癌细胞中甲状旁腺激素相关蛋白(PTHrP)和甲状旁腺激素/甲状旁腺激素相关蛋白受体的表达。
Pancreas. 2004 Aug;29(2):85-92. doi: 10.1097/00006676-200408000-00001.
10
Divalent cations modulate the integrin-mediated malignant phenotype in pancreatic cancer cells.二价阳离子调节胰腺癌细胞中整合素介导的恶性表型。
Cancer Sci. 2008 Aug;99(8):1553-63. doi: 10.1111/j.1349-7006.2008.00855.x.

引用本文的文献

1
Lacrimal Gland Inflammation Deregulates Extracellular Matrix Remodeling and Alters Molecular Signature of Epithelial Stem/Progenitor Cells.泪腺炎症失调细胞外基质重塑并改变上皮干细胞/祖细胞的分子特征。
Invest Ophthalmol Vis Sci. 2015 Dec;56(13):8392-402. doi: 10.1167/iovs.15-17477.
2
Divalent cations modulate alpha2beta1 integrin-mediated malignancy in a novel 3-dimensional in vitro model of pancreatic cancer.二价阳离子调节新型胰腺癌三维体外模型中α2β1 整合素介导的恶性肿瘤形成。
Pancreas. 2010 Aug;39(6):904-12. doi: 10.1097/MPA.0b013e3181ce60a3.
3
Type I collagen inhibits differentiation and promotes a stem cell-like phenotype in human colorectal carcinoma cells.

本文引用的文献

1
alpha5beta1 integrin stimulates Bcl-2 expression and cell survival through Akt, focal adhesion kinase, and Ca2+/calmodulin-dependent protein kinase IV.α5β1整合素通过Akt、粘着斑激酶和Ca2+/钙调蛋白依赖性蛋白激酶IV刺激Bcl-2表达并促进细胞存活。
J Cell Biochem. 2005 Aug 15;95(6):1214-23. doi: 10.1002/jcb.20488.
2
Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells.胰腺癌细胞通过刺激星状细胞的增殖和基质合成来诱导纤维化。
Gastroenterology. 2005 Apr;128(4):907-21. doi: 10.1053/j.gastro.2004.12.036.
3
Analysis of E-, N-cadherin, alpha-, beta-, and gamma-catenin expression in human pancreatic carcinoma cell lines.
I型胶原蛋白抑制人结肠癌细胞的分化并促进其干细胞样表型。
Br J Cancer. 2009 Jul 21;101(2):320-6. doi: 10.1038/sj.bjc.6605143. Epub 2009 Jun 30.
4
Divalent cations modulate the integrin-mediated malignant phenotype in pancreatic cancer cells.二价阳离子调节胰腺癌细胞中整合素介导的恶性表型。
Cancer Sci. 2008 Aug;99(8):1553-63. doi: 10.1111/j.1349-7006.2008.00855.x.
5
Integrin-mediated laminin-1 adhesion upregulates CXCR4 and IL-8 expression in pancreatic cancer cells.整合素介导的层粘连蛋白-1黏附上调胰腺癌细胞中CXCR4和IL-8的表达。
Surgery. 2007 Jun;141(6):804-14. doi: 10.1016/j.surg.2006.12.016. Epub 2007 May 4.
6
The alpha2beta1 integrin mediates the malignant phenotype on type I collagen in pancreatic cancer cell lines.α2β1整合素介导胰腺癌细胞系中I型胶原上的恶性表型。
Br J Cancer. 2006 May 8;94(9):1311-9. doi: 10.1038/sj.bjc.6603088.
人胰腺癌细胞系中E-钙黏蛋白、N-钙黏蛋白、α-连环蛋白、β-连环蛋白和γ-连环蛋白表达的分析。
Pancreas. 2005 Mar;30(2):168-73. doi: 10.1097/01.mpa.0000148514.69873.85.
4
GSK3 and PKB/Akt are associated with integrin-mediated regulation of PTHrP, IL-6 and IL-8 expression in FG pancreatic cancer cells.糖原合成酶激酶3(GSK3)和蛋白激酶B(PKB)/Akt与整合素介导的FG胰腺癌细胞中甲状旁腺激素相关蛋白(PTHrP)、白细胞介素-6(IL-6)和白细胞介素-8(IL-8)表达的调控有关。
Int J Cancer. 2005 Apr 20;114(4):522-30. doi: 10.1002/ijc.20748.
5
Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma.I型胶原蛋白促进胰腺导管腺癌的恶性表型。
Clin Cancer Res. 2004 Nov 1;10(21):7427-37. doi: 10.1158/1078-0432.CCR-03-0825.
6
TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling.转化生长因子-β通过抑制白细胞介素-6转信号传导来抑制结肠癌的肿瘤进展。
Immunity. 2004 Oct;21(4):491-501. doi: 10.1016/j.immuni.2004.07.020.
7
Down-regulation of the homeodomain factor Cdx2 in colorectal cancer by collagen type I: an active role for the tumor environment in malignant tumor progression.Ⅰ型胶原蛋白对结直肠癌中同源结构域因子Cdx2的下调作用:肿瘤环境在恶性肿瘤进展中的积极作用
Cancer Res. 2004 Oct 1;64(19):6973-7. doi: 10.1158/0008-5472.CAN-04-1132.
8
A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile.胰腺导管癌细胞系生物学行为的全面体外表征及其与结构和基因图谱的相关性。
Virchows Arch. 2004 Sep;445(3):236-47. doi: 10.1007/s00428-004-1053-x. Epub 2004 Jul 17.
9
The extracellular matrix differentially regulates the expression of PTHrP and the PTH/PTHrP receptor in FG pancreatic cancer cells.细胞外基质差异性调节FG胰腺癌细胞中甲状旁腺激素相关蛋白(PTHrP)和甲状旁腺激素/甲状旁腺激素相关蛋白受体的表达。
Pancreas. 2004 Aug;29(2):85-92. doi: 10.1097/00006676-200408000-00001.
10
A mitochondrial protein, Bit1, mediates apoptosis regulated by integrins and Groucho/TLE corepressors.一种线粒体蛋白Bit1介导由整合素和Groucho/TLE共抑制因子调控的细胞凋亡。
Cell. 2004 Mar 5;116(5):751-62. doi: 10.1016/s0092-8674(04)00204-1.